Croda International Plc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Croda International Plc with three other
pharmaceutical manufacturers in Europe:
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
of HUNGARY
(2019
sales of 507.79 billion Hungarian Forints [US$1.73 billion]
of which 78%
was Pharmaceutical Manufacturing and Sale),
Krka DD Novo Mesto
of SLOVENIA
(1.49 billion Euros [US$1.76 billion]
of which 59%
was European Union), and
Recordati Industria Chimica e Farmaceutica SpA
which is
based in ITALY
(1.48 billion Euros [US$1.75 billion]
of which 83%
was Specialty & Primary care).
Sales Analysis.
Croda International Plc reported sales of £1.38 billion (US$1.80 billion)
for the
year ending
December of 2019.
This
represents
a
decrease of 0.7%
versus 2018, when the company's sales were £1.39 billion.
Contributing to the drop in overall sales was the 5.7% decline
in Performance Technologies, from £456.40 million to £430.20 million.
There were also decreases in sales in
Personal Care (down 0.5% to £485.20 million)
and
Industrial Chemicals (down 5.4% to £111.80 million)
.
However, these declines were partially offset by the increase in sales of
Life Sciences (up 8.0% to £350.50 million)
.